| Title | Date | PubMed ID |
|---|
| Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations. | 2014 Nov 3 | 25362963 |
| Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors. | 2012 Mar | 22238126 |
| Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease. | 2009 Dec | 19798742 |
| Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use. | 2008 Apr | 18312292 |
| Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. | 2008 Feb 27 | 18304321 |
| In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir. | 2007 Sep | 17576848 |
| Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors. | 2007 Feb | 17116674 |
| HIV-2 Protease resistance defined in yeast cells. | 2006 Sep 6 | 16956392 |
| HIV protease cleaves poly(A)-binding protein. | 2006 Jun 1 | 16594896 |
| Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites. | 2005 Apr | 15767422 |